Current in vitro methods in nanoparticle risk assessment: limitations and challenges

Area of Science:

• Materials Science
• Toxicology
• Biotechnology

Background:

• Nanoparticles are functional materials with size-dependent properties, finding applications in medicine and industry.
• Increasing nanoparticle use raises human exposure risks, highlighting the need for reliable toxicity testing.
• Existing in vitro cytotoxicity tests, developed for chemicals, may not accurately assess nanoparticle hazards.

Purpose of the Study:

• To review current in vitro toxicity test methods for nanoparticles.
• To identify limitations of existing methods due to specific nanoparticle properties.
• To emphasize the need for validated and standardized nanoparticle toxicity assays.

Main Methods:

• Overview of current in vitro toxicity testing approaches for nanoparticles.
• Analysis of how nanoparticle characteristics (e.g., adsorption, hydrophobicity, surface charge, optical/magnetic properties, catalytic activity) interfere with assays.
• Discussion of the importance of material characterization and test system validation.

Main Results:

• Nanoparticle properties can significantly interfere with assay components and detection systems.
• Current in vitro methods often yield unreliable results for nanoparticles.
• Specific particle characterization and test validation are crucial for accurate toxicity assessment.

Conclusions:

• Development of new, standardized in vitro methods is essential for reliable nanoparticle risk assessment.
• Future research must focus on well-characterized materials and validated test applicability.
• Addressing the interference of nanoparticle properties in assays is key to advancing nanotoxicology.